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**Web appendix 1:** Further details of the PhysioDirect service

###### 

Click here for additional data file.

###### 

**Web appendix 2:** Reasons why referrals were ineligible for invitation

###### 

Click here for additional data file.

Introduction
============

Healthcare systems internationally face the challenge of how to meet increasing demand for healthcare, due to the ageing population and rising consumer expectations within limited resources. Healthcare providers therefore need to explore new approaches to delivering care. One approach that has been used in several contexts is initial assessment by telephone.[@ref1] This can make it convenient for patients to access advice or treatment (or both), and provides a triage function since patients who have most to gain from early face-to-face treatment can be identified and prioritised. Telephone based approaches have been introduced to assess and advise patients with a wide range of problems in primary care, although have rarely been rigorously evaluated.[@ref1]

This approach could be particularly appropriate for the assessment and treatment of musculoskeletal problems, which are one of the most common reasons for consulting a general practitioner.[@ref2] Musculoskeletal problems are an important cause of poor health because of pain and functional impairment[@ref3] and have a major economic effect owing to time lost from work, particularly from back pain.[@ref4] In the United Kingdom's health service, patients with musculoskeletal problems usually consult in general practice initially. Many are then referred to physiotherapy, with about 1.23 million new referrals from general practitioners per annum in England.[@ref5] These patients are put on a waiting list to see a physiotherapist for a face-to-face assessment, often followed by a series of follow-up appointments. Providing timely access to physiotherapy has long been a problem in the NHS, with waiting times of several weeks or months for treatment in many areas of the UK.[@ref6]

For some conditions such as neck pain[@ref7] and shoulder pain,[@ref8] there is evidence of benefit from manual therapy from a physiotherapist. However, for other conditions such as osteoarthritis,[@ref9] the main recommended treatment is advice about maintaining physical activities and provision of a structured exercise programme rather than hands on therapy. Therefore, waiting lists might be congested with patients who could benefit from assessment and advice from a physiotherapist, but could have little more to gain from a course of face-to-face appointments.

In an effort to improve access to care, several areas have introduced PhysioDirect services, in which patients can telephone a physiotherapist for initial assessment and advice without waiting for a face-to-face appointment. They can be given advice about self management and exercises over the telephone, and the need and priority for seeing them face-to-face can be established. Services that have implemented PhysioDirect have claimed that it reduces waiting times for treatment, it is popular with patients, and about half of all patients can be managed by telephone alone.[@ref10] [@ref11] This type of service is being introduced in several different countries, including the UK, but there is no evidence about health outcomes or costs.[@ref12] The aim of this study was to assess the clinical effectiveness and cost effectiveness of PhysioDirect compared with usual models of care based on patients joining a waiting list for physiotherapy and eventually receiving face-to-face care. This paper describes the findings with regard to the clinical effectiveness of PhysioDirect, along with findings about access to care and acceptability to patients. The economic analysis is reported elsewhere.[@ref13]

Methods
=======

Design
------

We conducted a pragmatic, individually randomised controlled trial, incorporating economic evaluation, to compare PhysioDirect and usual care.[@ref14] The trial was designed to assess equivalence between the two trial arms in the primary clinical outcome. If equivalence in clinical outcome is established, the parallel economic evaluation and secondary outcomes (such as waiting time for treatment) become particularly important and relevant to future provision of services. The only important change to the study design after it had commenced was an increase in the target number for recruitment, described below.

Setting and participants
------------------------

The trial was conducted in four typical community physiotherapy services in four different areas of England (Bristol, Somerset, Stoke-on-Trent, and Cheshire), which drew patients from 94 general practices covering a wide range of types of geographical area and population. Adults (aged ≥18 years) who were referred by general practitioners or who referred themselves for physiotherapy for a musculoskeletal problem were eligible for the trial. Inclusion criteria were deliberately broad to maximise generalisability. The main exclusion criteria were patients with non-musculoskeletal problems, referred by hospital consultants, unable to communicate in English by telephone, who could not be contacted, or with problems deemed (on the basis of the referral form) to be too urgent to be delayed by trial recruitment.

Interventions
-------------

In the UK, usual care typically involves patients with musculoskeletal problems being referred by general practitioners to a physiotherapist. Patients join a waiting list for the next available face-to-face appointment, and could wait for several weeks. After assessment, patients are usually given advice about exercises, supported by advice leaflets. If appropriate, they are invited to a course of further treatment sessions, which might involve hands-on manual therapies.

Patients randomly allocated to the PhysioDirect arm were invited to telephone a senior physiotherapist for initial assessment and advice about treatment as soon as it was convenient. Physiotherapists were available to receive calls during advertised PhysioDirect sessions. The physiotherapists used computerised templates to assess patients and record findings. As part of their training to provide the PhysioDirect service, physiotherapists were taught enhanced telephone communication skills, including the use of visualisation to help assess patients' symptoms and functional difficulties.

At the end of the call, most patients were sent written advice about self management and exercises and invited to telephone back after two to four weeks to discuss progress. They were then given further advice or offered face-to-face treatment as necessary. The PhysioDirect assessment also made it possible to identify patients who urgently needed face-to-face treatment and other patients who were unlikely to gain benefit from physiotherapy and could be discharged.

The PhysioDirect intervention was based on offering patients an initial telephone assessment with a physiotherapist, with face-to-face care available if necessary. Patients in the PhysioDirect arm could decline a telephone assessment at any time and wait for a face-to-face appointment. The comparison was between a PhysioDirect treatment pathway that offered early telephone advice that, by a system of triage, also allowed earlier face-to-face appointments if necessary, and the usual care system in which all patients waited for a face-to-face appointment.

The PhysioDirect services in each of the four sites were standardised as far as possible, with physiotherapists undergoing the same training,[@ref15] using the same assessment software, and providing the same range of advice leaflets. These advice leaflets were similar to those that may have been given to patients after consultations in the usual care arm.

Computerised assessment templates and training were provided by the physiotherapy team in Huntingdonshire, who have provided a similar PhysioDirect service since 2001.[@ref15] This study was completely independent, and none of the authors have any conflict of interest in relation to the success (or otherwise) of the intervention. Web appendix 1 provides further details of the PhysioDirect service.

Despite the 2:1 randomisation ratio in favour of PhysioDirect, most patients in each site continued to receive usual care, because it included not only those randomised to usual care but also those ineligible for the trial or declining participation. We allocated physiotherapy staff time in each site in proportion to the number of patients allocated to the PhysioDirect trial arm versus all those due to receive usual care. The time available for patients in the PhysioDirect arm included both telephone sessions and any subsequent face-to-face consultations. Therefore, total physiotherapy staff time per patient was similar in both trial arms. Separate waiting lists were held for patients in the PhysioDirect and usual care arms in each site. By these measures, we ensured that the PhysioDirect service did not affect the waiting time for patients in the usual care arm.

Randomisation and masking
-------------------------

Patients referred for physiotherapy were invited by post to participate. Those who gave informed consent were randomised in a 2:1 ratio to PhysioDirect or usual care using a secure remote automated allocation system generated and hosted by the Bristol Randomised Controlled Trials Collaboration. We used the 2:1 ratio to ensure that enough patients were randomised to PhysioDirect to make it viable to run PhysioDirect telephone sessions efficiently and at different times in the week. Randomisation was conducted at the level of the patient, stratifying by physiotherapy service and minimising by sex, patient age group, and site of musculoskeletal problem.

Outcomes were self reported in patient questionnaires or obtained by electronic download from the PhysioDirect software or from physiotherapy service records. If patients did not return questionnaires despite reminders, attempts were made to collect primary outcome data by telephone. All outcome data were collected by researchers who were blind to group allocation. It was not possible for physiotherapists delivering the intervention to be blinded.

Outcome measures
----------------

Outcomes were assessed at baseline, and at six weeks and six months after randomisation. We collected data for the process of care including the number, type, and duration of consultations with physiotherapists; waiting times for treatment (defined as first physiotherapy contact); and rates of non-attended appointments.

The primary outcome was clinical outcome at six months, assessed by the physical component summary measure from the SF-36v2 questionnaire.[@ref16] We used a generic measure because no disease specific measure was appropriate, in view of the wide range of problems experienced by patients in this trial. Despite concerns about the sensitivity of generic measures, the physical component score has been shown to compare well with disease specific measures in patients with musculoskeletal problems.[@ref17] [@ref18] [@ref19] [@ref20] To provide further reassurance that our measures were sufficiently sensitive to detect differences between the groups (particularly important given the equivalence nature of this trial), we also used four other measures of clinical outcome:

-   The Measure Yourself Medical Outcomes Profile, a tailored and validated measure that is generated by patients. By focusing on the main problem for which the patient was referred to physiotherapy, this profile would be particularly sensitive to change[@ref21]

-   The EQ-5D measure of health related quality of life[@ref22]

-   One question about overall improvement in the main problem for which the patient was referred to physiotherapy (global improvement score---a seven point scale from "very much better" to "very much worse")

-   A composite measure of response to treatment including pain, function, and overall improvement as recommended by the Outcomes Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International initiative[@ref23]

Other secondary outcomes included: the mental component summary score and individual scales from the SF-36v2 questionnaire, time lost from work, patient satisfaction, and patient preference for future care. Questions about satisfaction with the consultation were adapted from the General Practice Assessment Questionnaire, with additional questions about access to the service based on preliminary interviews with patients. We confirmed that these questions formed internally reliable scales using rotated factor analysis. Overall satisfaction with the service was based on one question. All questions used six point Likert scales.

Sample size and power
---------------------

The study was powered to establish clinical equivalence in the physical component score, with a difference of no greater than two points conservatively specified as demonstrating equivalence.[@ref16] Sample sizes for analysis of 976 and 488 patients in the PhysioDirect and usual care groups, respectively, would provide 95% power to reject a null hypothesis of non-equivalence with an overall two sided α of 0.05, assuming that the observed difference in means was 0 and standard deviation of the physical component score was 10.[@ref16]

Assuming 20% non-collection of the primary outcomes, it was necessary to recruit 1875 patients to reach a target of 1500 patients for analysis. Following a protocol amendment, we continued sending invitations until 2000 patients had been randomised, recognising that the final number recruited would be higher because of the lag between invitation and recruitment. This amendment was necessary because of concern about the follow-up rate we would achieve during a national postal strike.

Statistical methods
-------------------

We used descriptive statistics to compare characteristics of patients randomised with those eligible but not randomised and to assess the balance between the trial arms at baseline. Analyses of primary and secondary outcomes were conducted on an intention to treat basis without imputation---that is, all patients were analysed according to their randomised groups, except for those who did not provide follow-up data. We used multivariable regression models to investigate between group differences, adjusted for stratification and minimisation variables and, if available, the value of the outcome at baseline.

Although the protocol stated that we would make adjustments to P values arising from analyses of secondary outcomes to account for multiple testing, we later decided not to do so, as discussed in the limitations section of this paper.[@ref24] In sensitivity analyses, we investigated the effect of any baseline imbalance in outcome variables, clustering by physiotherapy service or general practice, and missing primary outcome data, using multiple imputation methods.[@ref25] In prespecified subgroup analyses, we explored the effect of PhysioDirect on the primary clinical outcome according to the site of presenting musculoskeletal problem, patient age group, socioeconomic status and physiotherapy service, using interaction terms in the primary regression analysis. All statistical analyses were conducted using Stata version 11.

Investigation of adverse events
-------------------------------

General practitioners and physiotherapists were asked to report any suspected adverse event that may have been related to physiotherapy or to the trial procedures. The general practice notes of each patient were scrutinised by researchers at the end of the trial following a protocol designed to identify any potential adverse events. Data about several other potential harms were available from the main outcome measures described previously, such as continued pain or reduced function (available from scales in the SF-36v2) and extended time off work (from the patient questionnaire).

Trial registration
------------------

The trial was registered with Current Controlled Trials (ISRCTN55666618) before patient recruitment, and the protocol has been published.[@ref14]

Results
=======

Participant flow and recruitment
--------------------------------

The figure[](#fig1){ref-type="fig"} illustrates the flow of patients during the trial. Of 4523 eligible patients, 2256 (50%) agreed to participate. Almost all patients (98%; 2207/2256) were referred by general practitioners, the remainder were self referred. Patients who were randomised were slightly younger on average than those who were not (mean age 48 years *v* 52 years), but were otherwise similar in terms of sex, deprivation, site, and referral problem. We recruited and randomised patients between July 2009 and December 2009; 1513 to PhysioDirect and 743 to usual care. Seven patients were found to have been randomised to PhysioDirect in error: two had not completed a valid consent form and five were subsequently found to have exclusion criteria for the trial. We excluded these patients from follow-up and analysis. There were no important differences between groups at baseline (table 1[](#tbl1){ref-type="table"}). Primary outcome data were obtained from 88% of patients after six weeks' follow-up and 85% of patients after six months' follow-up.

![CONSORT diagram: flow of participants through the trial. No English means that patients did not understand English. \*Percentages expressed as n/1506×100%. †Percentages expressed as n/743×100%](salc006076.f1_default){#fig1}

###### 

 Baseline characteristics of randomised patients\*

                                        No (%) of patients   
  ------------------------------------- -------------------- --------------
  Female sex†                           438 (59)             897 (60)
  Age (years)†‡                         48(36-62)            48(37-61)
  White ethnicity                       705 (96)             1,439 (97)
  Employed                              417 (57)             925 (62)
  Site of musculoskeletal problem†                           
   Cervical                             89 (12)              185 (12)
   Thoracic                             13 (2)               35 (2)
   Lumbar                               203 (27)             412 (27)
   Upper limb                           174 (23)             351 (23)
   Lower limb                           225 (30)             450 (30)
   Widespread pain                      7 (1)                8 (1)
   Multiple                             27 (4)               55 (4)
   Other                                4 (1)                10 (1)
  Primary care trust†                                        
   Bristol                              251 (34)             499 (33)
   Somerset                             165 (22)             348 (23)
   Cheshire                             174 (23)             353 (23)
   Stoke                                153 (21)             306 (20)
  Time off work (days)‡                 0 (0-5)              0 (0-5)
  SF-36v2 (physical component score)§   37.72 (8.63)         36.81 (8.88)

\*Excluding seven patients excluded after randomisation.

†Stratification/minimisation variable.

‡Median (interquartile range).

§Mean (standard deviation).

Process of care
---------------

Of all patients in the PhysioDirect arm, 1281 (85%) contacted the physiotherapy service at least once. Of the 1237 patients contacting PhysioDirect and assessed initially by telephone, 586 (47%) were managed entirely by telephone. Patients in the PhysioDirect arm had fewer face-to-face appointments than those in the usual care arm (mean 1.91 *v* 3.11; adjusted incidence rate ratio 0.59 (95% confidence interval 0.53 to 0.65)) and fewer physiotherapy consultations of any type (2.87 *v* 3.25, 0.87 (0.80 to 0.94)). Patients allocated to PhysioDirect had a shorter wait for physiotherapy treatment than those allocated to usual care (median 7 days *v* 34 days; adjusted arm time ratio 0.32 (0.29 to 0.35)). Patients in the PhysioDirect arm were also less likely to fail to attend face-to-face appointments over six months than those in the usual care arm (mean failure rate 0.09 *v* 0.12, adjusted incidence rate ratio 0.55 (0.41 to 0.73)).

Primary and secondary outcomes
------------------------------

PhysioDirect and usual care were equivalent in terms of the primary outcome of physical component score at six months' follow-up (table 2[](#tbl2){ref-type="table"}). This finding was robust to adjustment for baseline imbalance, imputation of missing data, and adjustment for clustering. All measures of health outcome (that is, the primary and four secondary outcomes) showed a similar pattern. These findings suggested a slightly greater improvement in favour of PhysioDirect at six weeks' follow-up, but no differences at six months' follow-up (tables 2 and 3[](#tbl3){ref-type="table"}). However, the differences at six weeks were small and could be clinically unimportant.

###### 

 Between group differences in SF-36v2 physical component score

  Time after randomisation   Mean (standard deviation) score, sample size   Difference (95% CI)\*   P                       
  -------------------------- ---------------------------------------------- ----------------------- ----------------------- ------
  6 weeks                    41.81 (10.30), 653                             41.57(10.26), 1332      0.42 (−0.28 to 1.12)    0.24
  6 months†                  44.18 (10.84), 629                             43.50 (10.94), 1283     −0.01 (−0.80 to 0.79)   0.99

\*Adjusted for outcome at baseline, sex, age, referral problem, and primary care trust.

†Defined as the primary follow-up point.

###### 

 Between group differences in secondary health related outcomes

                                                             Mean (SD) score, sample size   Regression analysis\*                            
  ---------------------------------------------------------- ------------------------------ ----------------------- ------------------------ -------
  Measure Yourself Medical Outcomes Profile†                                                                                                 
   Baseline                                                  3.80 (0.99), 743               3.84 (0.99), 1504       ---                      ---
   6 weeks                                                   2.92 (1.21), 561               2.76 (1.28), 1101       −0.19 (−0.30 to −0.07)   0.001
   6 months                                                  2.40 (1.38), 518               2.40 (1.43), 1033       −0.02 (−0.16 to 0.11)    0.73
  EQ-5D‡                                                                                                                                     
   Baseline                                                  0.56 (0.29), 731               0.53 (0.30), 1480       ---                      ---
   6 weeks                                                   0.64 (0.26), 554               0.64 (0.27), 1080       0.01 (−0.01 to 0.03)     0.29
   6 months                                                  0.69 (0.27), 508               0.69 (0.27), 1020       0.01 (−0.02 to 0.03)     0.61
  Global improvement score‡                                                                                                                  
   Baseline                                                  NA                             NA                      NA                       NA
   6 weeks                                                   3.54 (1.19), 552               3.69 (1.28), 1089       0.15 (0.02 to 0.28)      0.02
   6 months                                                  4.07 (1.40), 501               4.01 (1.44), 1001       −0.08 (−0.23 to 0.08)    0.32
  Response to treatment using OMERACT-OARSI criteria^23^‡§                                                                                   
  ** **                                                      NA                             NA                      NA                       NA
   6 weeks                                                   124 (22.6)/550                 306 (28.2)/1085         1.37 (1.08 to 1.75)      0.01
   6 months                                                  197 (38.6)/510                 430 (41.8)/1029         1.14 (0.92 to 1.43)      0.24

NA=not applicable; OMERACT=Outcome Measures in Rheumatology; OARSI=Osteroarthritis Research Society International; SD=standard deviation.

\*Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.

†Lower value indicates better outcome.

‡Higher value indicates better outcome.

§Data are no (%) of participants who responded/total sample size, and odds ratio (95% confidence interval).

Table 4[](#tbl4){ref-type="table"} shows no differences between study groups for the mental component summary measure or any of the scales from the SF-36v2 questionnaire. No evidence was found of a difference between the two trial arms in time lost from work (table 5[](#tbl5){ref-type="table"}). Patients in the usual care arm had slightly higher satisfaction than those in the PhysioDirect arm with regards to the consultation and overall satisfaction. No between group difference was evident with regards to satisfaction with access to the service (table 6[](#tbl6){ref-type="table"}).

###### 

 Mental component scores and individual scales from the SF-36v2 questionnaire by trial arm and follow-up period

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                Mean (standard deviation) score, sample size                       Regression analysis\* (arm difference (95% CI), P)                                                                                                                      
  ---------------------- ---------------------------------------------- ------------------- ---------------------------------------------------- ------------------ ------------------- -- ------------------- ------------------- -- ----------------------------- -----------------------------
  Mental component\      45.7 (13.3), 743                               46.1 (12.6), 1504                                                        48.7 (12.2), 653   48.7 (12), 1332        48.7 (11.8), 629    49 (11.9), 1283        −0.03 (−0.88 to 0.82), 0.94   0.11 (−0.83 to 1.05), 0.82
  score                                                                                                                                                                                                                                                             

  Physical functioning   39.9 (10.2), 743                               39.3 (10.4), 1506                                                        43.0 (10.8), 656   43.0 (10.9), 1338      45.2 (10.8), 632    44.7 (11.2), 1284      0.52 (−0.19 to 1.23), 0.14    0.00 (−0.75 to 0.75), 1.00

  Role-physical          37.4 (11.2), 743                               36.7 (10.9), 1502                                                        43.2 (11.6), 655   43.0 (11.3), 1336      45.5 (11.5), 630    45.0 (11.5), 1284      0.27 (−0.60 to 1.15), 0.52    −0.08 (−1.00 to 0.84), 0.86

  Bodily pain            34.9 (8.2), 743                                34.6 (8.2), 1506                                                         41.1 (9.6), 657    40.9 (9.9), 1338       43.2 (10.5), 632    43.1 (10.6), 1284      0.06 (−0.68 to 0.80), 0.89    0.04 (−0.81 to 0.90), 0.93

  General health         45.1 (10.5), 743                               44.6 (10.7), 1506                                                        45.9 (10.5), 657   45.3 (10.8), 1338      46.1 (10.6), 634    45.7 (11.1), 1284      −0.07 (−0.66 to 0.51), 0.81   −0.14 (−0.79 to 0.51), 0.66

  Vitality               43.7 (10.6), 743                               43.4 (10.7), 1506                                                        46.3 (10.8), 655   46.3 (10.8), 1334      47.4 (10.5), 632    47.0 (11.1), 1283      0.35 (−0.40 to 1.11), 0.35    −0.23 (−1.05 to 0.60), 0.59

  Social functioning     40.4 (12.8), 743                               39.8 (12.6), 1504                                                        45.1 (12.2), 657   45.0 (12.4), 1338      46.1 (12.0), 632    46.2 (12.2), 1284      0.25 (−0.69 to 1.18), 0.58    0.34 (−0.61 to 1.30), 0.48

  Role-emotional         42.1 (14.6), 743                               42.3 (14.3), 1498                                                        46.6 (12.7), 655   46.2 (12.9), 1334      47.1 (12.2), 630    47.1 (12.4), 1283      −0.32 (−1.24 to 0.59), 0.51   −0.06 (−1.07 to 0.95), 0.92

  Mental health          45.4 (11.7), 743                               45.8 (11.4), 1506                                                        47.9 (11.4), 655   48.2 (11.2), 1334      48.3 (11.44), 632   48.7 (11.3), 1283      0.24 (−0.55 to 1.02), 0.57    0.18 (−0.67 to 1.04), 0.72
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

UC=usual care; PD=PhysioDirect.

\*Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.

###### 

 Between group differences in time lost from work.\* Data are mean (standard deviation), median (interquartile range), and sample size, unless stated otherwise

  Reason for time lost from work        Usual care                     PhysioDirect                 Arm time ratio (95% CI)†   P
  ------------------------------------- ------------------------------ ---------------------------- -------------------------- ------
  Condition for which referred (days)                                                                                          
   Baseline                             3.10 (7.72), 0 (0-2), 395      3.00 (7.53), 0 (0-2), 866    NA                         NA
   6 weeks                              5.35 (15.22), 0 (0-2), 253     4.39 (11.44), 0 (0-2), 511   −0.95 (−3.02 to 1.05)      0.27
   6 months                             7.14 (22.24), 0 (0-2), 200     7.01 (18.03), 0 (0-3), 390   0.08 (−3.21 to 3.35)       0.94
  Physiotherapy (h)                                                                                                            
   Baseline                             NA                             NA                           NA                         NA
   6 weeks                              0.40 (1.21), 0 (0-0), 656      0.40 (2.35), 0 (0-0), 1340   −0.01 (−0.14 to 0.18)      0.94
   6 months                             0.98 (2.80), 0 (0 to 0), 598   0.95 (4.73), 0 (0-0), 1211   −0.04 (−0.37 to 0.33)      0.85

NA=not applicable.

\*Analysis only included patients who were in work.

†Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.

###### 

 Between group differences in patient satisfaction at six week and six month follow-up

                                                 Satisfaction (% of maximum score\* (mean (SD)), sample size)   Regression analysis†                         
  ---------------------------------------------- -------------------------------------------------------------- ---------------------- --------------------- ---------
  Satisfaction with physiotherapy consultation                                                                                                               
   6 weeks                                       82.5 (17.6), 378                                               77.6 (18.7), 890       −4.9 (−7.1 to −2.7)   \<0.001
   6 months                                      79.2 (19.2), 368                                               75.7 (20.1), 750       −3.4 (−5.9 to 0.97)   0.005
  Satisfaction with access to physiotherapy                                                                                                                  
   6 weeks                                       71.4 (21.1), 381                                               70.6 (22.3), 869       −0.8 (−3.4 to 1.7)    0.502
   6 months                                      69.1 (20.8), 367                                               69.2 (22.0), 740       0.1 (−2.7 to 2.8)     0.960
  Overall satisfaction with service                                                                                                                          
   6 weeks                                       83.7 (25.2), 383                                               77.3 (27.4), 885       −6.5 (−9.6 to −3.4)   \<0.001
   6 months                                      79.7 (26.5), 367                                               75.9 (28.3), 739       −3.8 (−7.3 to −0.3)   0.031

\*Higher scores indicate greater satisfaction.

†Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.

At baseline, about a third of participants in each arm stated a preference for usual care, stated a preference for PhysioDirect, or expressed indifference. At six months' follow up, 417 (42%) of 985 patients in the PhysioDirect group and 245 (51%) of 485 patients in the usual care group preferred usual care; 393 (40%) and 131 (27%) in each group, respectively, preferred PhysioDirect. Multinomial logistic regression showed strong evidence that participants in the PhysioDirect arm were more likely than those in the usual care arm to prefer PhysioDirect compared with being indifferent (adjusted relative risk ratio 1.98 (adjusted 95% confidence interval 1.43 to 1.98)).

No differences between trial arms in the primary outcome were identified in relation to any of the prespecified subgroups (based on age, referral problem, deprivation, or primary care trust site), but potentially important differences could not be excluded because the confidence intervals were wide (data not shown). No adverse events were detected in either arm of the trial, which included 4323 consultations (1445 by telephone) over six months in 1506 patients allocated to PhysioDirect.

Discussion
==========

Compared with usual care based on waiting lists for face-to-face appointments, a care pathway based on PhysioDirect is equally clinically effective, provides faster access to advice and treatment, and seems to be safe. However, there was no evidence that this pathway was associated with improved patient satisfaction with access to physiotherapy.

Strengths and limitations
-------------------------

Innovations in the delivery of healthcare are rarely accompanied by large, multicentre, randomised controlled trials such as the present trial, including an analysis of cost effectiveness.[@ref26] The findings show that randomised trials of service reorganisation are feasible and are also informative in challenging assumptions---for example, that faster access to care will reduce patients' time off work or improve satisfaction with the service.

However, our study also highlights the limitations of trials of service innovations.[@ref27] For example, providing a new service in the context of a trial meant providing two different care pathways in parallel, which made it difficult to provide PhysioDirect services throughout the week so that patients could call when it suited them. Once the trial ended, far more patients were treated with PhysioDirect by the services that continued to offer it (because there was no consenting process and none were randomised to usual care), and it was possible to provide a more efficient and accessible PhysioDirect service than was tested during the trial.

We observed few differences in outcomes between groups. The differences in clinical outcomes seen after six weeks' follow-up might be too small to be clinically meaningful. However, the pattern of change over time was consistent across several different measures of clinical outcome, supporting the notion that patients allocated to PhysioDirect had a faster improvement in symptoms than those allocated to usual care.

The difference in patient satisfaction was also small and might not be meaningful, with a 3.8% difference in overall satisfaction, equating to 0.19 points on a six point scale ranging from "very poor" to "excellent." The fact that patients in the PhysioDirect arm (of whom almost half (47%) were managed entirely by telephone) were almost as satisfied with their consultations as patients in the usual care arm (of whom almost all had face-to-face consultations only) might provide reassurance that physiotherapists are able to provide assessments and advice by telephone in a way that is reasonably acceptable to patients.

The findings about patient satisfaction were also limited because these questions were only answered by people who had had contact with a physiotherapist. By six weeks' follow-up, 50% of the patients in the usual care arm (compared with 19% of those in the PhysioDirect arm) had not had any contact. These patients did not complete the questionnaire but may have been those most likely to express dissatisfaction with access.

We did not make adjustments to P values arising from analyses of secondary outcomes to account for multiple testing, which is at variance from the protocol. Our focus was on the magnitude of between arm differences in outcomes using confidence intervals, rather than hypothesis testing using P values, as a basis for interpretation and decision making. The subject of adjustment for multiple testing has been debated at length by statisticians,[@ref24] and on reflection we decided that the adjustment as stated in the protocol was unnecessary in this case.

The pragmatic nature of this study, which includes a wide range of patients and several physiotherapy sites, makes the findings potentially generalisable to physiotherapy services in the NHS, as well as to the many other countries in which patients experience long delays in accessing physiotherapy.[@ref28] However, only 50% of eligible patients agreed to participate. Although this rate of recruitment was high for a community based trial, and no important differences were observed between participants and non-participants, the rate still raises questions about external validity. We do not have data about whether people declined because they did not wish to take part in research or did not want to receive PhysioDirect. However, our recruitment rate suggests that at least 50% would consider using PhysioDirect if it were offered.

Implications
------------

This study provides justification for PhysioDirect as a safe and effective way of reducing delays for advice about musculoskeletal problems for patients referred by general practitioners for physiotherapy. But, in view of the slight reduction in patient satisfaction, our results do not provide a compelling argument in favour of PhysioDirect. However, our associated economic analysis (reported elsewhere)[@ref13] suggests that the slightly earlier advice and treatment provided by PhysioDirect means that the service is likely to be more cost effective than usual pathways of care from a health service perspective, which will be of interest to commissioners.

In future, PhysioDirect services will probably be provided more often in conjunction with direct access for patients to physiotherapists (rather than after referral from another healthcare professional), and PhysioDirect could be offered as a choice for patients wanting quicker advice rather than as the only route to care.[@ref29] Patients who self refer will probably have less serious problems of shorter duration than those referred by general practitioners,[@ref29] and in these circumstances, the benefits of initial telephone assessment and advice via PhysioDirect could be greater.

The PhysioDirect services in this study used experienced physiotherapists to provide telephone assessments supported by computerised assessment templates. Some PhysioDirect services that have been recently established use less experienced physiotherapists who are not supported by computerised templates. It should not be assumed that our findings are applicable under these circumstances.

### What is already known on this topic

1.  Under the PhysioDirect care pathway, patients are invited to telephone a physiotherapist for initial assessment and advice, followed by face-to-face physiotherapy if necessary

2.  Several observational studies have suggested benefits of PhysioDirect services for patients with musculoskeletal problems, in relation to improved process of care and patient satisfaction

3.  Research on similar systems of telephone assessment and advice in other clinical settings has shown that they can be safe, clinically accurate, cost effective, and acceptable to patients, and can reduce clinicians' workload

### What this study adds

1.  Half of the patients referred by general practitioners to physiotherapy could be managed by telephone, reducing delays for initial treatment advice and non-attendance rates at subsequent face-to-face appointments

2.  PhysioDirect was as clinically effective as usual care (based on joining waiting lists for appointments without telephone consultation), and seemed to be safe

3.  Reduced delays for physiotherapy were not associated with increased patient satisfaction with access to care, and overall satisfaction of patients was slightly lower for PhysioDirect than for usual care
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